Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Stomach Neoplasms 7Barrett Esophagus 7Gastritis 5Breast Neoplasms 4Stomach Ulcer 3Peptic Ulcer 3Gastroesophageal Reflux 3Dyspepsia 3Zollinger-Ellison Syndrome 2Esophageal Neoplasms 2Colorectal Neoplasms 2Vomiting 1Radiation Esophagitis 1Precancerous Conditions 1Peptic Ulcer Hemorrhage 1Neoplasms 1Neoplasm Metastasis 1Nausea 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Hot Flashes 1Hemorrhage 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Esophagitis, Peptic 1Esophagitis 1Dysbiosis 1Colonic Neoplasms 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 92Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 52Doxorubicin 50trametinib 47atezolizumab 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Esomeprazole × Clear all
NCT03708211 2020-12-29

A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors

Takeda

Phase 1 Completed
20 enrolled 23 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡